Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000147077 | SCV000170894 | benign | not specified | 2013-04-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000147077 | SCV000194427 | likely benign | not specified | 2013-03-27 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000147077 | SCV000231617 | benign | not specified | 2014-05-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000463342 | SCV000559643 | benign | Developmental and epileptic encephalopathy, 9 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312911 | SCV000847603 | benign | Inborn genetic diseases | 2016-07-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |